These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17276687)

  • 1. Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents.
    Martins C; Gunaratnam M; Stuart J; Makwana V; Greciano O; Reszka AP; Kelland LR; Neidle S
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2293-8. PubMed ID: 17276687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
    Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
    J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
    Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
    J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)-substituted acridines as potent telomeric G-quadruplex ligands.
    Laronze-Cochard M; Kim YM; Brassart B; Riou JF; Laronze JY; Sapi J
    Eur J Med Chem; 2009 Oct; 44(10):3880-8. PubMed ID: 19467742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors.
    Schultes CM; Guyen B; Cuesta J; Neidle S
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4347-51. PubMed ID: 15261300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors.
    Read M; Harrison RJ; Romagnoli B; Tanious FA; Gowan SH; Reszka AP; Wilson WD; Kelland LR; Neidle S
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4844-9. PubMed ID: 11309493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of a series of fluoroquinoanthroxazines with contrasting dual mechanisms of action against topoisomerase II and G-quadruplexes.
    Kim MY; Duan W; Gleason-Guzman M; Hurley LH
    J Med Chem; 2003 Feb; 46(4):571-83. PubMed ID: 12570378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
    Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
    Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trisubstituted acridine derivatives as potent and selective telomerase inhibitors.
    Harrison RJ; Cuesta J; Chessari G; Read MA; Basra SK; Reszka AP; Morrell J; Gowan SM; Incles CM; Tanious FA; Wilson WD; Kelland LR; Neidle S
    J Med Chem; 2003 Oct; 46(21):4463-76. PubMed ID: 14521409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.
    Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S
    J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-quadruplexes as therapeutic targets.
    Neidle S; Read MA
    Biopolymers; 2000-2001; 56(3):195-208. PubMed ID: 11745111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recognition of higher-order G-quadruplex by chiral cyclic-helicene molecules.
    Xu Y; Yamazaki S; Osuga H; Sugiyama H
    Nucleic Acids Symp Ser (Oxf); 2006; (50):183-4. PubMed ID: 17150878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural investigations of acridine derivatives by CoMFA and CoMSIA reveal novel insight into their structures toward DNA G-quadruplex mediated telomerase inhibition and offer a highly predictive 3D-model for substituted acridines.
    Zambre VP; Murumkar PR; Giridhar R; Yadav MR
    J Chem Inf Model; 2009 May; 49(5):1298-311. PubMed ID: 19413274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase.
    Perry PJ; Read MA; Davies RT; Gowan SM; Reszka AP; Wood AA; Kelland LR; Neidle S
    J Med Chem; 1999 Jul; 42(14):2679-84. PubMed ID: 10411488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New highly hydrosoluble and not self-aggregated perylene derivatives with three and four polar side-chains as G-quadruplex telomere targeting agents and telomerase inhibitors.
    Franceschin M; Pascucci E; Alvino A; D'Ambrosio D; Bianco A; Ortaggi G; Savino M
    Bioorg Med Chem Lett; 2007 May; 17(9):2515-22. PubMed ID: 17317176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells.
    Gunaratnam M; Neidle S
    Methods Mol Biol; 2010; 613():303-13. PubMed ID: 19997892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
    Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
    Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer.
    Folini M; Pivetta C; Zagotto G; De Marco C; Palumbo M; Zaffaroni N; Sissi C
    Biochem Pharmacol; 2010 Jun; 79(12):1781-90. PubMed ID: 20206144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.